On April 24, 2025, Helius Medical Technologies, Inc. entered into a securities purchase agreement to sell $1,560,000 in unsecured promissory notes and issue 1,320,150 shares of common stock, expected to close on April 25, 2025. The proceeds will be used for working capital and other corporate purposes.